前进两步，后退一步：美国霉酚酸酯治疗重症肌无力的情况 - Suppr

Suppr

超能文献

Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.

作者信息

Burns Ted M, Sanders Donald B, Kaminski Henry J, Wolfe Gil I, Narayanaswami Pushpa, Venitz Jurgen

机构信息

University of Virginia, Department of Neurology, Charlottesville, Virginia, USA.

出版信息

Muscle Nerve. 2015 May;51(5):635-7. doi: 10.1002/mus.24608. Epub 2015 Mar 31.

DOI:10.1002/mus.24608

PMID:25704880

Abstract

摘要

相似文献

Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.

Muscle Nerve. 2015 May;51(5):635-7. doi: 10.1002/mus.24608. Epub 2015 Mar 31.

The muddle of mycophenolate mofetil in myasthenia.

Neurology. 2008 Aug 5;71(6):390-1. doi: 10.1212/01.wnl.0000324254.97372.e0.

Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil.

Neurology. 1998 Sep;51(3):912-3. doi: 10.1212/wnl.51.3.912-a.

Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.

Neurology. 2003 Nov 25;61(10):1438-40. doi: 10.1212/01.wnl.0000094122.88929.0b.

Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection.

Eur Neurol. 2001;46(1):53-4. doi: 10.1159/000050759.

Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study.

Ann N Y Acad Sci. 2003 Sep;998:494-9. doi: 10.1196/annals.1254.064.

Mycophenolate mofetil in the therapy of severe myasthenia gravis.

Eur Neurol. 2001;46(2):79-82. doi: 10.1159/000050768.

Mycophenolate mofetil treatment of myasthenia gravis.

Ann Pharmacother. 2006 Feb;40(2):295-8. doi: 10.1345/aph.1G501. Epub 2006 Jan 10.

Mycophenolate mofetil in myasthenia gravis: the unanswered question.

Expert Opin Pharmacother. 2008 Oct;9(14):2545-51. doi: 10.1517/14656566.9.14.2545.

Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.

Intern Med J. 2007 Jan;37(1):55-9. doi: 10.1111/j.1445-5994.2006.01222.x.

引用本文的文献

Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma-inactivated protein 1 encephalitis: a prospective observational cohort study.

Neurol Sci. 2024 Jan;45(1):253-260. doi: 10.1007/s10072-023-06968-6. Epub 2023 Aug 15.

Current Treatment of Myasthenia Gravis.

J Clin Med. 2022 Mar 14;11(6):1597. doi: 10.3390/jcm11061597.

History of Myasthenia Gravis Revisited.

Noro Psikiyatr Ars. 2020 Nov 7;58(2):154-162. doi: 10.29399/npa.27315. eCollection 2021 Jun.

From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research.

Front Neurol. 2020 Sep 2;11:981. doi: 10.3389/fneur.2020.00981. eCollection 2020.

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

Cochrane Database Syst Rev. 2020 Jan 25;1(1):CD008630. doi: 10.1002/14651858.CD008630.pub5.

[Myasthenia gravis].

Nervenarzt. 2019 Oct;90(10):1055-1066. doi: 10.1007/s00115-019-00798-8.

Immunotherapy in myasthenia gravis in the era of biologics.

Nat Rev Neurol. 2019 Feb;15(2):113-124. doi: 10.1038/s41582-018-0110-z.

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

Cochrane Database Syst Rev. 2016 Nov 15;11(11):CD008630. doi: 10.1002/14651858.CD008630.pub4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.

作者信息

Burns Ted M, Sanders Donald B, Kaminski Henry J, Wolfe Gil I, Narayanaswami Pushpa, Venitz Jurgen

机构信息

University of Virginia, Department of Neurology, Charlottesville, Virginia, USA.

出版信息

Muscle Nerve. 2015 May;51(5):635-7. doi: 10.1002/mus.24608. Epub 2015 Mar 31.

DOI:10.1002/mus.24608

PMID:25704880

Abstract

摘要

相似文献

Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.

Muscle Nerve. 2015 May;51(5):635-7. doi: 10.1002/mus.24608. Epub 2015 Mar 31.

The muddle of mycophenolate mofetil in myasthenia.

Neurology. 2008 Aug 5;71(6):390-1. doi: 10.1212/01.wnl.0000324254.97372.e0.

Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil.

Neurology. 1998 Sep;51(3):912-3. doi: 10.1212/wnl.51.3.912-a.

Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.

Neurology. 2003 Nov 25;61(10):1438-40. doi: 10.1212/01.wnl.0000094122.88929.0b.

Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection.

Eur Neurol. 2001;46(1):53-4. doi: 10.1159/000050759.

Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study.

Ann N Y Acad Sci. 2003 Sep;998:494-9. doi: 10.1196/annals.1254.064.

Mycophenolate mofetil in the therapy of severe myasthenia gravis.

Eur Neurol. 2001;46(2):79-82. doi: 10.1159/000050768.

Mycophenolate mofetil treatment of myasthenia gravis.

Ann Pharmacother. 2006 Feb;40(2):295-8. doi: 10.1345/aph.1G501. Epub 2006 Jan 10.

Mycophenolate mofetil in myasthenia gravis: the unanswered question.

Expert Opin Pharmacother. 2008 Oct;9(14):2545-51. doi: 10.1517/14656566.9.14.2545.

Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.

Intern Med J. 2007 Jan;37(1):55-9. doi: 10.1111/j.1445-5994.2006.01222.x.

引用本文的文献

Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma-inactivated protein 1 encephalitis: a prospective observational cohort study.

Neurol Sci. 2024 Jan;45(1):253-260. doi: 10.1007/s10072-023-06968-6. Epub 2023 Aug 15.

Current Treatment of Myasthenia Gravis.

J Clin Med. 2022 Mar 14;11(6):1597. doi: 10.3390/jcm11061597.

History of Myasthenia Gravis Revisited.

Noro Psikiyatr Ars. 2020 Nov 7;58(2):154-162. doi: 10.29399/npa.27315. eCollection 2021 Jun.

From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research.

Front Neurol. 2020 Sep 2;11:981. doi: 10.3389/fneur.2020.00981. eCollection 2020.

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

Cochrane Database Syst Rev. 2020 Jan 25;1(1):CD008630. doi: 10.1002/14651858.CD008630.pub5.

[Myasthenia gravis].

Nervenarzt. 2019 Oct;90(10):1055-1066. doi: 10.1007/s00115-019-00798-8.

Immunotherapy in myasthenia gravis in the era of biologics.

Nat Rev Neurol. 2019 Feb;15(2):113-124. doi: 10.1038/s41582-018-0110-z.

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

Cochrane Database Syst Rev. 2016 Nov 15;11(11):CD008630. doi: 10.1002/14651858.CD008630.pub4.